Charles Schwab Investment Management Inc Ultragenyx Pharmaceutical Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 594,521 shares of RARE stock, worth $26.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
594,521
Previous 537,616 10.58%
Holding current value
$26.6 Million
Previous $22.1 Million 49.46%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$40.21 - $59.36 $2.29 Million - $3.38 Million
56,905 Added 10.58%
594,521 $33 Million
Q2 2024

Aug 12, 2024
BUY
$37.42 - $51.61 $1.99 Million - $2.75 Million
53,235 Added 10.99%
537,616 $22.1 Million
Q1 2024

May 08, 2024
BUY
$43.02 - $53.69 $540,159 - $674,131
12,556 Added 2.66%
484,381 $22.6 Million
Q4 2023

Feb 06, 2024
BUY
$31.73 - $49.19 $2.38 Million - $3.69 Million
75,100 Added 18.93%
471,825 $22.6 Million
Q3 2023

Nov 08, 2023
BUY
$34.92 - $46.66 $680,486 - $909,263
19,487 Added 5.17%
396,725 $14.1 Million
Q2 2023

Aug 09, 2023
BUY
$37.35 - $52.15 $234,408 - $327,293
6,276 Added 1.69%
377,238 $17.4 Million
Q1 2023

May 11, 2023
SELL
$36.99 - $48.71 $48,530 - $63,907
-1,312 Reduced 0.35%
370,962 $14.9 Million
Q4 2022

Feb 13, 2023
BUY
$33.72 - $46.33 $241,704 - $332,093
7,168 Added 1.96%
372,274 $17.2 Million
Q3 2022

Nov 14, 2022
SELL
$39.96 - $66.14 $7.43 Million - $12.3 Million
-186,020 Reduced 33.75%
365,106 $15.1 Million
Q2 2022

Aug 15, 2022
BUY
$45.8 - $85.4 $475,495 - $886,622
10,382 Added 1.92%
551,126 $32.9 Million
Q1 2022

May 13, 2022
BUY
$62.2 - $84.4 $905,694 - $1.23 Million
14,561 Added 2.77%
540,744 $39.3 Million
Q4 2021

Feb 11, 2022
BUY
$73.71 - $87.86 $909,139 - $1.08 Million
12,334 Added 2.4%
526,183 $44.2 Million
Q3 2021

Nov 16, 2021
BUY
$77.92 - $102.4 $1.31 Million - $1.71 Million
16,748 Added 3.37%
513,849 $46.3 Million
Q2 2021

Aug 16, 2021
SELL
$92.19 - $115.71 $9.43 Million - $11.8 Million
-102,330 Reduced 17.07%
497,101 $47.4 Million
Q1 2021

May 17, 2021
BUY
$106.9 - $167.73 $6 Million - $9.42 Million
56,157 Added 10.34%
599,431 $68.3 Million
Q4 2020

Feb 16, 2021
BUY
$84.4 - $177.39 $4.31 Million - $9.06 Million
51,080 Added 10.38%
543,274 $75.2 Million
Q3 2020

Nov 13, 2020
BUY
$72.98 - $90.0 $8.57 Million - $10.6 Million
117,402 Added 31.32%
492,194 $40.5 Million
Q2 2020

Aug 14, 2020
BUY
$46.91 - $78.22 $1.49 Million - $2.48 Million
31,693 Added 9.24%
374,792 $29.3 Million
Q1 2020

May 15, 2020
BUY
$33.8 - $62.9 $254,175 - $473,008
7,520 Added 2.24%
343,099 $15.2 Million
Q4 2019

Feb 07, 2020
BUY
$36.08 - $45.83 $212,366 - $269,755
5,886 Added 1.79%
335,579 $14.3 Million
Q3 2019

Nov 08, 2019
BUY
$42.5 - $63.11 $479,187 - $711,565
11,275 Added 3.54%
329,693 $14.1 Million
Q2 2019

Aug 09, 2019
BUY
$54.93 - $74.36 $956,605 - $1.29 Million
17,415 Added 5.79%
318,418 $20.2 Million
Q1 2019

May 14, 2019
BUY
$39.87 - $69.36 $1.57 Million - $2.73 Million
39,392 Added 15.06%
301,003 $20.9 Million
Q4 2018

Feb 14, 2019
BUY
$38.89 - $77.3 $129,659 - $257,718
3,334 Added 1.29%
261,611 $11.4 Million
Q3 2018

Nov 13, 2018
BUY
$71.81 - $90.15 $973,528 - $1.22 Million
13,557 Added 5.54%
258,277 $19.7 Million
Q2 2018

Aug 08, 2018
BUY
$48.54 - $85.31 $1.05 Million - $1.84 Million
21,566 Added 9.66%
244,720 $18.8 Million
Q1 2018

May 07, 2018
BUY
$44.33 - $58.52 $2.24 Million - $2.96 Million
50,615 Added 29.34%
223,154 $11.4 Million
Q4 2017

Jan 17, 2018
SELL
$43.54 - $57.32 $388,855 - $511,924
-8,931 Reduced 4.92%
172,539 $8 Million
Q3 2017

Nov 13, 2017
BUY
$49.79 - $66.32 $9.04 Million - $12 Million
181,470
181,470 $9.67 Million

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.13B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email